Table 1.
Patient characteristics
| All patients | Patients having lesions with LTP | Patients having lesions without LTP | |
|---|---|---|---|
| Patientsa | 71 (100) | 24 (31) | 53 (75) |
| Age (years)b | 68.3±10.2 (49.6–85.9) | 69.1±10.6 (51.6–85.7) | 68.4±10.3 (49.6–85.7) |
| Male | 50 (70) | 17 (71) | 38 (72) |
| Received pre-RF ablation chemotherapy | 54 (76) | 17 (71) | 41 (77) |
| Received post-RF ablation chemotherapy | 48 (68) | 18 (75) | 35 (67) |
| Follow-up (months) | 23.7±10.8 (7.0–54.3) | 23.7±10.4 (10.8–54.3) | 23.7±10.9 (7.0–52.0) |
| Deceased at last follow-up | 20 (28) | 8 (33) | 15 (28) |
Data are presented as n (%) or mean±standard deviation (range).
LTP, local tumor progression; RF, radiofrequency.
a
Of the patients with multiple metastases, six had some metastases with local tumor progression and other metastases without local tumor progression.
b
Age at the time of the radiofrequency ablation procedure.